The second reading of the Narcotic Drugs Amendment (medicinal cannabis) Bill 2021 ('the Bill') was passed in the Senate without amendment on June 17 2021.
The Bill will introduce a single licence for the cultivation, production and manufacture of and research into medicinal cannabis. This aims to reduce the administrative burden on industry; however, it remains unclear whether these benefits will result in better processing times and reduced costs for patients.
Read more here.